ReviewFrontiers in chemistry2026
Machine learning for the prediction of gram-negative bacterial secreted effectors: advances and challenges.
Review in Frontiers in chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurately identifying virulence-associated proteins secreted by Gram-negative pathogens is essential for elucidating bacterial pathogenic mechanisms and developing novel antimicrobial interventions. However, traditional experimental approaches for effector identification are time-consuming and labor-intensive. Recent advances in machine learning (ML), ranging from handcrafted features to context-aware embeddings derived from protein language models, have significantly improved secreted effector prediction. Here, we provide a systematic overview of ML-based methods for secreted effector prediction, surveying available database resources, negative dataset construction strategies, feature representation approaches, and model architectures spanning classical machine learning to deep learning. We discuss fundamental challenges, including data scarcity and class imbalance, evaluation bias, and model interpretability. Finally, we outline future directions encompassing multimodal data integration, meta-learning to address data limitations, and uncertainty quantification to enhance predictive robustness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.